Searching for neurological manifestations similar to HMNDYT1, we find no association with Parkinson’s disease or dystonia but note that, as with liver diseases, we are powered to exclude only strong effects because of the small case number for these traits (Supplementary Data 7). Here, SLC30A10 is linked to liver disorder.